Skip to content

AngioDynamics ANGO Cash Flow Statement

Q3 '26Q2 '26Q1 '26Q4 '25Q3 '25
-$8.08M-27.3%-$6.35M+41.8%-$10.9M-80.2%-$6.05M-37.3%-$4.41M+59.0%
$5.59M-2.7%$5.75M-4.5%$6.02M+3.2%$5.83M-7.7%$6.32M-7.9%
$2.68M-7.2%$2.89M-35.3%$4.47M+172%$1.64M-31.6%$2.4M-5.1%
-$3.11M-$15.91M-$13.16M
$1.02M+141%$422K-42.3%$731K-5.9%$777K-56.8%$1.8M+126%
-$1.51M+7.0%-$1.62M-4.5%-$1.55M+40.9%-$2.62M+17.7%-$3.19M-62.6%
$0$0$0
$621K$143K+102%-$5.77M-181%$7.15M+736%
-$3.83M-$17.13M-$9.33M-918%
-$4.13M-$16.65M-$14.96M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does AngioDynamics generate?
AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
What is AngioDynamics's free cash flow?
After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
Where does AngioDynamics's cash flow data come from?
Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.